Comparison of Different Promoter Methylation Assays in Breast Cancer

Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influe...

Descripción completa

Detalles Bibliográficos
Autores principales: Suijkerbuijk, Karijn P. M., Pan, Xiaojuan, van der Wall, Elsken, van Diest, Paul J., Vooijs, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2010
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605677/
https://www.ncbi.nlm.nih.gov/pubmed/20978321
http://dx.doi.org/10.3233/ACP-CLO-2010-0542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605677/
https://www.ncbi.nlm.nih.gov/pubmed/20978321
http://dx.doi.org/10.3233/ACP-CLO-2010-0542

Ejemplares similares